By Dr. Mercola
By Dr. Mercola
Sanofi Pasteur announced that its dengue vaccine, Dengvaxia, may lead to more severe cases of dengue fever in some people — a warning it relayed after the vaccine was already administered to more than 700,000 children in the Philippines. Those at risk, according to Sanofi, are people who have not been previously infected by dengue virus.
Their new analysis that evaluated long-term safety and efficacy of the vaccine revealed that “in the longer term, more cases of severe disease could occur following vaccination upon a subsequent dengue infection.”1
As a result, the Philippines has launched an investigation and …read more
Source: mercola
Thanks! Share it with your friends!
Tweet
Share
Pin It
LinkedIn
Google+
Reddit
Tumblr